Literature DB >> 31330440

Arginine metabolism and deprivation in cancer therapy.

Songyun Zou1, Xiangmei Wang1, Po Liu1, Changneng Ke2, Shi Xu3.   

Abstract

Certain cancer cells with nutrient auxotrophy and have a much higher nutrient demand compared with normal human cells. Arginine as a versatile amino acid, has multiple biological functions in metabolic and signaling pathways. Depletion of this amino acid by arginine depletor is generally well tolerated and has become a targeted therapy for arginine auxotrophic cancers. However, the modulatory eff ;ect of arginine on cancer cells is very complicated and still controversial. Therefore, this article focuses on arginine metabolism and depletion therapy in cancer treatment to provide systemical review on this issue.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Arginine; Cancer; Deprivation; Metabolism

Mesh:

Substances:

Year:  2019        PMID: 31330440     DOI: 10.1016/j.biopha.2019.109210

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  30 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

Review 2.  The hallmarks of cancer metabolism: Still emerging.

Authors:  Natalya N Pavlova; Jiajun Zhu; Craig B Thompson
Journal:  Cell Metab       Date:  2022-02-04       Impact factor: 27.287

3.  Effects of Exogenous ATP on Melanoma Growth and Tumor Metabolism in C57BL/6 Mice.

Authors:  Yali Lei; Xu Zhou; Yang Zhao; Jianfa Zhang
Journal:  Comp Med       Date:  2022-04-11       Impact factor: 1.565

Review 4.  Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.

Authors:  Neha Kumari; Saurabh Bansal
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-26       Impact factor: 3.333

5.  Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.

Authors:  Ji-Min Li; David C Yang; Justin Oldham; Angela Linderholm; Jun Zhang; Jun Liu; Nicholas J Kenyon; Ching-Hsien Chen
Journal:  Mol Ther       Date:  2021-01-26       Impact factor: 11.454

6.  Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.

Authors:  Cheng-Ying Chu; Yi-Ching Lee; Cheng-Han Hsieh; Chi-Tai Yeh; Tsu-Yi Chao; Po-Hung Chen; I-Hsuan Lin; Tsung-Han Hsieh; Jing-Wen Shih; Chia-Hsiung Cheng; Che-Chang Chang; Ping-Sheng Lin; Yuan-Li Huang; Tsung-Ming Chen; Yun Yen; David K Ann; Hsing-Jien Kung
Journal:  Theranostics       Date:  2021-01-25       Impact factor: 11.556

Review 7.  Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.

Authors:  Lin Zhao; Yuanyuan Liu; Simiao Zhang; Lingyu Wei; Hongbing Cheng; Jinsheng Wang; Jia Wang
Journal:  Cell Death Dis       Date:  2022-04-20       Impact factor: 9.685

Review 8.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

9.  Intracellular expression of arginine deiminase activates the mitochondrial apoptosis pathway by inhibiting cytosolic ferritin and inducing chromatin autophagy.

Authors:  Qingyuan Feng; Xuzhao Bian; Xuan Liu; Ying Wang; Huiting Zhou; Xiaojing Ma; Chunju Quan; Yi Yao; Zhongliang Zheng
Journal:  BMC Cancer       Date:  2020-07-16       Impact factor: 4.430

Review 10.  Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer.

Authors:  Johannes F Fahrmann; Jody V Vykoukal; Edwin J Ostrin
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.